Showing results (51-60 of 431) with videos related to
Sort By:
Pageof 44
Cancer Chemotherapy and Pharmacology|August 3, 2015
Phase I dose-finding and pharmacokinetic study of docetaxel and gefitinib in patients with advanced or metastatic non-small-cell lung cancer: evaluation of drug-drug interactionMasanori Motonaga, Noboru Yamamoto, Yoshinori Makino, et al.Pharmacogenomics|October 21, 2022
Association between genetic variants and the risk of nivolumab-induced immune-related adverse eventsChihiro Udagawa, Mari Hara Nakano, Teruhiko Yoshida, et al.BMC Pulmonary Medicine|January 10, 2022
Concurrent chemoradiotherapy with cisplatin + S-1 versus cisplatin + other third-generation agents for locally advanced non-small-cell lung cancer: a meta-analysis of individual participant dataYuri Taniguchi, Hiroaki Okamoto, Tsuneo Shimokawa, et al.Cancer Chemotherapy and Pharmacology|April 28, 2009
A dose-finding and pharmacokinetic study of nedaplatin in elderly patients with advanced non-small cell lung cancerNoboru Yamamoto, Tomohide Tamura, Takayasu Kurata, et al.Lung Cancer (Amsterdam, Netherlands)|January 24, 2002
Phase II study of docetaxel and cisplatin administered as three consecutive weekly infusions for advanced non-small cell lung cancerSeiji Niho, Yuichiro Ohe, Ryutaro Kakinuma, et al.Japanese Journal of Clinical Oncology|July 25, 2014
Low-dose irinotecan as a second-line chemotherapy for recurrent small cell lung cancerMasahiro Morise, Seiji Niho, Shigeki Umemura, et al.Clinical Lung Cancer|March 6, 2016
Clinical Impact of Gastric Acid-Suppressing Medication Use on the Efficacy of Erlotinib and Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer Harboring EGFR MutationsYoshitaka Zenke, Kiyotaka Yoh, Shingo Matsumoto, et al.Lung Cancer (Amsterdam, Netherlands)|November 26, 2015
RECIST progression patterns during EGFR tyrosine kinase inhibitor treatment of advanced non-small cell lung cancer patients harboring an EGFR mutationTatsuya Yoshida, Kiyotaka Yoh, Seiji Niho, et al.ESMO Open|May 17, 2018
Reduction in nephrotoxicities using short hydration for chemotherapy containing cisplatin: a consecutive analysis of 467 patients with thoracic malignanciesMidori Tanaka, Hidehito Horinouchi, Yasushi Goto, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 9, 2023
Five Cases of Cytokine Release Syndrome in Patients Receiving Cytotoxic Chemotherapy Together With Nivolumab Plus Ipilimumab: A Case ReportYoshimasa Shiraishi, Takaaki Tokito, Ryo Toyozawa, et al.Pageof 44